Form 4: Lam Research CEO Sells Shares Under 10b5-1 Plan

Lam Research Corporation's President and CEO, Timothy Archer, reported the sale of 30,000 common shares under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Timothy Archer, President and CEO of Lam Research Corp (LRCX), executed a transaction on July 2, 2026.
• He sold 30,000 shares of common stock at a price of $390.01 per share.
• This sale was conducted under a Rule 10b5-1 trading plan adopted on February 24, 2026.
• Following this transaction, Archer beneficially owns 1,075,966 shares directly.
• The reported amount also includes shares subject to unvested restricted stock units.
• Additionally, Archer holds 48,025.745 shares indirectly through his 401(k) and 5,670.026 shares indirectly through his spouse's 401(k).
• The filing also notes an employee stock option with a conversion price of $30.033, with 30,000 shares underlying it, and it becomes exercisable in installments through March 2, 2023.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a slightly negative sentiment due to the significant sale by the CEO, despite the transaction being conducted under a pre-established plan.

Positives

• The transaction was executed under a Rule 10b5-1 plan, indicating pre-planned and potentially non-insider trading activity.
• The CEO retains a significant number of shares (1,075,966 directly) after the sale, suggesting continued confidence in the company.
• The stock options mentioned are exercisable, indicating potential future value realization for the executive.

Negatives

• The CEO sold a substantial number of shares (30,000), which could be perceived negatively by the market.
• The sale price of $390.01 per share represents a significant value realization for the executive.

Risks

• The primary risk is the market perception of a CEO selling a large block of shares, potentially signaling a lack of confidence or a belief that the stock is overvalued, despite being executed under a 10b5-1 plan.
• The unvested restricted stock units included in the beneficial ownership count mean that the actual number of fully owned, liquid shares is lower than the total reported.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports a past transaction.

Management Comments

• "This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2026."
• "The amount reported includes shares subject to unvested restricted stock units."
• "The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023."

Industry Context

StockSavvy.ai notes that insider selling, even under a Rule 10b5-1 plan, is a common event for executives to diversify their holdings or meet financial obligations. However, the scale and timing relative to company news can influence market interpretation. Lam Research operates in the highly competitive semiconductor equipment manufacturing sector.

Stakeholder Impact

• Shareholders: May interpret the CEO's sale as a negative signal, potentially impacting short-term stock price, although the 10b5-1 plan mitigates concerns about insider knowledge.
• Employees: May view the sale with mixed emotions, depending on their confidence in the company's future performance and the CEO's continued commitment.
• Management: The sale is a personal financial decision by the CEO, not directly impacting operational management, but could influence internal discussions on stock valuation.

Next Steps

• Monitor future SEC filings for any additional transactions by Timothy Archer or other insiders.
• Observe market reaction to this sale in conjunction with other company news.

Key Dates

Recommendation

The filing reports a standard insider sale under a Rule 10b5-1 plan. While the sale of 30,000 shares by the CEO is notable, it does not provide sufficient information to warrant a buy or sell recommendation. The CEO retains a substantial ownership stake, and the transaction was pre-planned, mitigating concerns about adverse non-public information. Therefore, a 'hold' recommendation is appropriate pending further company performance data or strategic announcements.

Keywords

Lam Research Corp, LRCX, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Timothy Archer, CEO, Beneficial Ownership, Stock Options, Restricted Stock Units